BRAIDWELL LP
Filing Date
Global Rank
#836
/ 8,232
▲ 79
Top Industry
Biotechnology
62.8%
3Y Alpha vs SPY
-11.0%
Period ended 2 months ago
Filed May 15, 2026 · 30d
14 quarters · since Dec 2022
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+34.1%
SPY
+76.3%
Annualised alpha
-10.5%
Max drawdown
−39.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
82 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
5.5%
−2.8 pts
Top 5
17.8%
−6.9 pts
Top 10
31.6%
−6.3 pts
HHI
197
Diversified−67
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $2,616,195,636 |
| Financial Services | 0.3% | $9,144,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
19 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | +2,258,258 | 3,206,574 | $52,748,142 | |
| MRVI | Maravai Lifesciences Holdings, Inc. | +1,886,877 | 10,240,164 | $28,979,664 | |
| NEO | Neogenomics Inc | +984,601 | 5,617,402 | $41,681,122 | |
| ZURA | Zura Bio Ltd | +808,600 | 3,988,989 | $23,734,484 | |
| CDNA | CareDx, Inc. | +587,926 | 2,173,146 | $37,725,814 | |
| MBX | MBX Biosciences, Inc. | +473,867 | 1,492,467 | $44,550,139 | |
| ACAD | Acadia Pharmaceuticals Inc | +439,178 | 2,471,199 | $55,008,889 | |
| IRTC | iRhythm Holdings, Inc. | +392,847 | 610,192 | $72,014,859 | |
| DRUG | Bright Minds Biosciences Inc. | +215,350 | 539,708 | $39,382,492 | |
| DYN | Dyne Therapeutics, Inc. | +203,669 | 1,681,998 | $30,494,623 | |
| CAI | Caris Life Sciences, Inc. | +193,305 | 8,009,447 | $143,208,912 | |
| HNGE | Hinge Health, Inc. | +150,500 | 1,455,123 | $56,109,542 | |
| INSP | Inspire Medical Systems, Inc. | +136,680 | 677,570 | $34,949,060 | |
| FULC | Fulcrum Therapeutics, Inc. | +73,700 | 3,134,922 | $24,044,851 | |
| ARGX | Argenx SE | +53,932 | 84,939 | $62,026,704 | |
| DHR | Danaher Corp /De/ | +21,100 | 139,327 | $26,416,399 | |
| NTRA | Natera, Inc. | +17,500 | 129,000 | $25,798,710 | |
| TMDX | TransMedics Group, Inc. | +14,050 | 329,391 | $32,744,759 | |
| TMO | Thermo Fisher Scientific Inc. | +12,190 | 92,915 | $45,670,509 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | −2,863,248 | 2,347,583 | $73,948,864 | |
| CGON | CG Oncology, Inc. | −885,788 | 984,783 | $66,650,113 | |
| CMPX | Compass Therapeutics, Inc. | −821,672 | 1,965,106 | $10,395,410 | |
| SYRE | Spyre Therapeutics, Inc. | −701,792 | 932,823 | $47,051,592 | |
| ENGN | enGene Therapeutics Inc. | −674,449 | 2,456,870 | $16,731,284 | |
| CLDX | Celldex Therapeutics, Inc. | −502,027 | 1,356,082 | $43,014,921 | |
| XENE | Xenon Pharmaceuticals Inc. | −486,624 | 1,338,452 | $77,830,983 | |
| NRIX | Nurix Therapeutics, Inc. | −433,098 | 1,750,766 | $27,136,873 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −374,571 | 899,364 | $75,474,626 | |
| CVS | CVS HEALTH Corp | −273,500 | 290,700 | $20,878,074 | |
| VERA | Vera Therapeutics, Inc. | −260,918 | 523,824 | $21,073,439 | |
| KOD | Kodiak Sciences Inc. | −254,123 | 1,818,665 | $69,327,509 | |
| SLNO | Soleno Therapeutics Inc | −228,600 | 959,259 | $32,115,991 | |
| CNTA | Centessa Pharmaceuticals plc | −201,552 | 1,986,768 | $78,914,424 | |
| BTSG | BrightSpring Health Services, Inc. | −179,224 | 1,016,562 | $43,315,706 | |
| GKOS | GLAUKOS Corp | −158,474 | 763,505 | $82,198,948 | |
| HROW | Harrow, Inc. | −138,872 | 156,419 | $5,515,333 | |
| NUVL | Nuvalent, Inc. | −120,977 | 700,429 | $71,758,951 | |
| KYMR | Kymera Therapeutics, Inc. | −116,700 | 337,559 | $28,115,289 | |
| BMRN | Biomarin Pharmaceutical Inc | −104,500 | 497,020 | $28,076,659 | |
| NBIX | Neurocrine Biosciences Inc | −99,413 | 652,121 | $85,910,420 | |
| APGE | Apogee Therapeutics, Inc. | −96,400 | 478,667 | $40,289,401 | |
| XFOR | X4 Pharmaceuticals, Inc | −95,950 | 3,272,954 | $13,517,300 | |
| TECX | Tectonic Therapeutic, Inc. | −80,373 | 847,151 | $26,185,437 | |
| SRZN | Surrozen, Inc./DE | −73,900 | 396,100 | $11,538,393 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GH | Guardant Health, Inc. | 499,712 | $46,158,397 | |
| GENB | Generate Biomedicines, Inc. | 3,592,999 | $44,912,487 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 310,628 | $27,015,317 | |
| ESTA | Establishment Labs Holdings Inc. | 463,600 | $26,323,208 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 1,752,798 | $25,643,434 | |
| ATEC | Alphatec Holdings, Inc. | 2,172,725 | $23,639,248 | |
| DMRA | Damora Therapeutics, Inc. | 894,846 | $23,176,511 | |
| BSX | Boston Scientific Corp | 346,467 | $21,740,804 | |
| BIOA | BioAge Labs, Inc. | 1,200,587 | $20,998,266 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 265,715 | $18,639,907 | |
| ELV | Elevance Health, Inc. | 62,080 | $18,173,920 | |
| NKTR | Nektar Therapeutics | 222,701 | $16,023,336 | |
| ACHC | Acadia Healthcare Company, Inc. | 645,900 | $15,107,601 | |
| ORIC | Oric Pharmaceuticals, Inc. | 1,128,040 | $14,292,266 | |
| AVAH | Aveanna Healthcare Holdings, Inc. | 2,203,506 | $14,190,578 | |
| TGTX | Tg Therapeutics, Inc. | 358,800 | $11,919,336 | |
| CNC | Centene Corp | 330,000 | $10,804,200 | |
| CLYM | Climb Bio, Inc. | 1,529,675 | $10,478,273 | |
| IONS | Ionis Pharmaceuticals Inc | 130,862 | $9,826,427 | |
| HLXC | Helix Acquisition Corp. III | 900,000 | $9,144,000 | |
| VOR | Vor Biopharma Inc. | 466,774 | $8,327,248 | |
| RVMD | Revolution Medicines, Inc. | 84,900 | $8,256,525 | |
| ACRS | Aclaris Therapeutics, Inc. | 1,699,116 | $6,371,685 | |
| DNLI | Denali Therapeutics Inc. | 296,324 | $5,689,420 | |
| RVTY | Revvity, Inc. | 48,400 | $4,240,324 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALGN | Align Technology Inc | 381,004 | $59,493,774 | |
| LEGN | Legend Biotech Corp | 1,298,142 | $28,221,607 | |
| TERN | Terns Pharmaceuticals, Inc. | 575,321 | $23,242,968 | |
| BIIB | Biogen Inc. | 115,700 | $20,362,043 | |
| ICLR | Icon PLC | 73,370 | $13,369,481 | |
| RLMD | Relmada Therapeutics, Inc. | 1,582,257 | $7,642,301 | |
| XNCR | Xencor Inc | 459,166 | $7,029,831 | |
| CSTL | Castle Biosciences Inc | 177,183 | $6,892,418 | |
| ADPT | Adaptive Biotechnologies Corp | 311,991 | $5,066,733 | |
| BLLN | BillionToOne, Inc. | 50,000 | $4,092,000 | |
| ORKA | Oruka Therapeutics, Inc. | 84,795 | $2,570,136 | |
| KPTI | Karyopharm Therapeutics Inc. | 303,370 | $2,232,803 | |
| No positions match the current search. | ||||
82 positions ·
$2,625,339,636 total
· as of Mar 31, 2026
Showing 1–50
of 82 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Added | 8,009,447 | $143,208,912 | 5.45% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 652,121 | $85,910,420 | 3.27% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 763,505 | $82,198,948 | 3.13% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 1,986,768 | $78,914,424 | 3.01% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 1,338,452 | $77,830,983 | 2.96% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 899,364 | $75,474,626 | 2.87% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 2,347,583 | $73,948,864 | 2.82% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 610,192 | $72,014,859 | 2.74% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 700,429 | $71,758,951 | 2.73% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Reduced | 1,818,665 | $69,327,509 | 2.64% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 984,783 | $66,650,113 | 2.54% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 84,939 | $62,026,704 | 2.36% | |
| HNGE |
Hinge Health, Inc.
Healthcare
|
Added | 1,455,123 | $56,109,542 | 2.14% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 2,471,199 | $55,008,889 | 2.10% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 3,206,574 | $52,748,142 | 2.01% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 182,425 | $47,124,026 | 1.79% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 932,823 | $47,051,592 | 1.79% | |
| GH |
Guardant Health, Inc.
Healthcare
|
NEW | 499,712 | $46,158,397 | 1.76% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 92,915 | $45,670,509 | 1.74% | |
| GENB |
Generate Biomedicines, Inc.
Healthcare
|
NEW | 3,592,999 | $44,912,487 | 1.71% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 1,492,467 | $44,550,139 | 1.70% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 1,016,562 | $43,315,706 | 1.65% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,356,082 | $43,014,921 | 1.64% | |
| NEO |
Neogenomics Inc
Healthcare
|
Added | 5,617,402 | $41,681,122 | 1.59% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 478,667 | $40,289,401 | 1.53% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 539,708 | $39,382,492 | 1.50% | |
| CDNA |
CareDx, Inc.
Healthcare
|
Added | 2,173,146 | $37,725,814 | 1.44% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 77,297 | $35,633,144 | 1.36% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Added | 677,570 | $34,949,060 | 1.33% | |
| PEN |
Penumbra Inc
Healthcare
|
Reduced | 105,352 | $34,594,436 | 1.32% | |
| TMDX |
TransMedics Group, Inc.
Healthcare
|
Added | 329,391 | $32,744,759 | 1.25% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 959,259 | $32,115,991 | 1.22% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,681,998 | $30,494,623 | 1.16% | |
| MRVI |
Maravai Lifesciences Holdings, Inc.
Healthcare
|
Added | 10,240,164 | $28,979,664 | 1.10% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Reduced | 229,215 | $28,253,040 | 1.08% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 337,559 | $28,115,289 | 1.07% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 497,020 | $28,076,659 | 1.07% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 1,750,766 | $27,136,873 | 1.03% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 310,628 | $27,015,317 | 1.03% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 139,327 | $26,416,399 | 1.01% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
NEW | 463,600 | $26,323,208 | 1.00% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Reduced | 847,151 | $26,185,437 | 1.00% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 129,000 | $25,798,710 | 0.98% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,752,798 | $25,643,434 | 0.98% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Added | 3,134,922 | $24,044,851 | 0.92% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 3,988,989 | $23,734,484 | 0.90% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
NEW | 2,172,725 | $23,639,248 | 0.90% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 894,846 | $23,176,511 | 0.88% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 346,467 | $21,740,804 | 0.83% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 523,824 | $21,073,439 | 0.80% |